All of the following drugs are used in the management of MDR-TB under RNTCP except
PAS is an add-on agent(D GROUP) and is not a core pa of MDR-TB drug regimen. The remaining 3 drugs are being given in both intensive as well as continuation phase of the regimen.
Levofloxacin
PAS
Ethionamide
Cycloserine
RNTCP